Henrik Lövborg - Search Results

Year	Number of Results
2002	2
2003	1
2004	2
2005	1
2006	6
2007	4
2009	3
2012	2
2014	1
2015	1
2016	1
2017	1
2024	0

1

Screening for apoptosis--classical and emerging techniques.

Lövborg H, Gullbo J, Larsson R. Lövborg H, et al. Anticancer Drugs. 2005 Jul;16(6):593-9. doi: 10.1097/00001813-200507000-00001. Anticancer Drugs. 2005. PMID: 15930885 Review.

2

Increased Risk of Drug-Induced Hyponatremia during High Temperatures.

Jönsson AK, Lövborg H, Lohr W, Ekman B, Rocklöv J. Jönsson AK, et al. Among authors: lovborg h. Int J Environ Res Public Health. 2017 Jul 22;14(7):827. doi: 10.3390/ijerph14070827. Int J Environ Res Public Health. 2017. PMID: 28737683 Free PMC article.

3

A fatal outcome after unintentional overdosing of rivastigmine patches.

Lövborg H, Jönsson AK, Hägg S. Lövborg H, et al. Curr Drug Saf. 2012 Feb;7(1):30-2. doi: 10.2174/157488612800492717. Curr Drug Saf. 2012. PMID: 22663954 Free article.

4

Image-based screening for the identification of novel proteasome inhibitors.

Rickardson L, Wickström M, Larsson R, Lövborg H. Rickardson L, et al. Among authors: lovborg h. J Biomol Screen. 2007 Mar;12(2):203-10. doi: 10.1177/1087057106297115. Epub 2007 Jan 4. J Biomol Screen. 2007. PMID: 17208922

5

Medication errors related to transdermal opioid patches: lessons from a regional incident reporting system.

Lövborg H, Holmlund M, Hägg S. Lövborg H, et al. BMC Pharmacol Toxicol. 2014 Jun 9;15:31. doi: 10.1186/2050-6511-15-31. BMC Pharmacol Toxicol. 2014. PMID: 24912424 Free PMC article.

6

Identification and evaluation of potential anti-cancer drugs on human neuroendocrine tumor cell lines.

Larsson DE, Lövborg H, Rickardson L, Larsson R, Oberg K, Granberg D. Larsson DE, et al. Among authors: lovborg h. Anticancer Res. 2006 Nov-Dec;26(6B):4125-9. Anticancer Res. 2006. PMID: 17201123 Free article.

7

Mechanism of action of cytotoxic cyclotides: cycloviolacin O2 disrupts lipid membranes.

Svangård E, Burman R, Gunasekera S, Lövborg H, Gullbo J, Göransson U. Svangård E, et al. Among authors: lovborg h. J Nat Prod. 2007 Apr;70(4):643-7. doi: 10.1021/np070007v. Epub 2007 Mar 23. J Nat Prod. 2007. PMID: 17378610

8

The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo.

Wickström M, Johnsen JI, Ponthan F, Segerström L, Sveinbjörnsson B, Lindskog M, Lövborg H, Viktorsson K, Lewensohn R, Kogner P, Larsson R, Gullbo J. Wickström M, et al. Among authors: lovborg h. Mol Cancer Ther. 2007 Sep;6(9):2409-17. doi: 10.1158/1535-7163.MCT-07-0156. Mol Cancer Ther. 2007. PMID: 17876040

9

Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram.

Lövborg H, Oberg F, Rickardson L, Gullbo J, Nygren P, Larsson R. Lövborg H, et al. Int J Cancer. 2006 Mar 15;118(6):1577-80. doi: 10.1002/ijc.21534. Int J Cancer. 2006. PMID: 16206267 Free article.

10

Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients.

Wickström M, Danielsson K, Rickardson L, Gullbo J, Nygren P, Isaksson A, Larsson R, Lövborg H. Wickström M, et al. Among authors: lovborg h. Biochem Pharmacol. 2007 Jan 1;73(1):25-33. doi: 10.1016/j.bcp.2006.08.016. Epub 2006 Aug 26. Biochem Pharmacol. 2007. PMID: 17026967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year